195 related articles for article (PubMed ID: 32336482)
1. Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine.
Yamanaka G; Suzuki S; Takeshita M; Go S; Morishita N; Takamatsu T; Daida A; Morichi S; Ishida Y; Oana S; Nara S; Shimura M; Nishimata S; Kawashima H
Brain Dev; 2020 Aug; 42(7):523-528. PubMed ID: 32336482
[TBL] [Abstract][Full Text] [Related]
2. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
Bruijn J; Duivenvoorden H; Passchier J; Locher H; Dijkstra N; Arts WF
Cephalalgia; 2010 Dec; 30(12):1426-34. PubMed ID: 20974610
[TBL] [Abstract][Full Text] [Related]
3. Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
Das R; Qubty W
Pediatr Neurol; 2021 Jan; 114():5-8. PubMed ID: 33189027
[TBL] [Abstract][Full Text] [Related]
4. Pediatric mixed headache -The relationship between migraine, tension-type headache and learning disabilities - in a clinic-based sample.
Genizi J; Khourieh Matar A; Schertz M; Zelnik N; Srugo I
J Headache Pain; 2016; 17():42. PubMed ID: 27102119
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine.
Yamanaka G; Go S; Morichi S; Takeshita M; Morishita N; Suzuki S; Tomoko T; Kasuga A; Daida A; Ishida Y; Oana S; Suganami Y; Nagao R; Kashiwagi Y; Kawashima H
J Child Neurol; 2020 Sep; 35(10):667-673. PubMed ID: 32476572
[TBL] [Abstract][Full Text] [Related]
6. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of migraine headaches with riboflavin: A systematic review.
Thompson DF; Saluja HS
J Clin Pharm Ther; 2017 Aug; 42(4):394-403. PubMed ID: 28485121
[TBL] [Abstract][Full Text] [Related]
8. Unsatisfactory response to acute medications does not affect the medication overuse headache development in pediatric chronic migraine.
Frattale I; Ferilli MAN; Ursitti F; Sforza G; Monte G; Proietti Checchi M; Tarantino S; Mazzone L; Valeriani M; Papetti L
J Headache Pain; 2024 Apr; 25(1):61. PubMed ID: 38649822
[TBL] [Abstract][Full Text] [Related]
9. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
10. Riboflavin prophylaxis in pediatric and adolescent migraine.
Condò M; Posar A; Arbizzani A; Parmeggiani A
J Headache Pain; 2009 Oct; 10(5):361-5. PubMed ID: 19649688
[TBL] [Abstract][Full Text] [Related]
11. The Profile and Prognosis of Youth With Status Migrainosus: Results From an Observational Study.
Orr SL; Turner A; Kabbouche MA; Horn PS; O'Brien HL; Kacperski J; LeCates S; White S; Weberding J; Miller MN; Powers SW; Hershey AD
Headache; 2020 May; 60(5):878-888. PubMed ID: 32031255
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine.
Hagan KK; Li W; Mostofsky E; Bertisch SM; Vgontzas A; Buettner C; Mittleman MA
Headache; 2021 Mar; 61(3):493-499. PubMed ID: 33349935
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.
Schoenen J; Jacquy J; Lenaerts M
Neurology; 1998 Feb; 50(2):466-70. PubMed ID: 9484373
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of riboflavin in pediatric migraine prevention.
Sherwood M; Goldman RD
Can Fam Physician; 2014 Mar; 60(3):244-6. PubMed ID: 24627379
[TBL] [Abstract][Full Text] [Related]
15. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial.
MacLennan SC; Wade FM; Forrest KM; Ratanayake PD; Fagan E; Antony J
J Child Neurol; 2008 Nov; 23(11):1300-4. PubMed ID: 18984840
[TBL] [Abstract][Full Text] [Related]
16. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
17. Headache disability among adolescents: a student population-based study.
Fuh JL; Wang SJ; Lu SR; Liao YC; Chen SP; Yang CY
Headache; 2010 Feb; 50(2):210-8. PubMed ID: 19804389
[TBL] [Abstract][Full Text] [Related]
18. Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine.
Orr SL; Kabbouche MA; Horn PS; O'Brien HL; Kacperski J; LeCates S; White S; Weberding J; Miller MN; Powers SW; Hershey AD
Headache; 2018 Sep; 58(8):1194-1202. PubMed ID: 29926909
[TBL] [Abstract][Full Text] [Related]
19. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre.
Boehnke C; Reuter U; Flach U; Schuh-Hofer S; Einhäupl KM; Arnold G
Eur J Neurol; 2004 Jul; 11(7):475-7. PubMed ID: 15257686
[TBL] [Abstract][Full Text] [Related]
20. A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.
Lombard L; Ye W; Nichols R; Jackson J; Cotton S; Joshi S
Headache; 2020 Jul; 60(7):1325-1339. PubMed ID: 32510611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
